Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Stone

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
Clinical Spine Surgery|November 23, 2016
The Influence of Histologic Subtype in Predicting Survival of Lung Cancer Patients With Spinal MetastasesNaresh Kumar, Kimberly-Anne Tan, Jiong Hao Tan, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort studyEmily Stone, Nicole Rankin, Stephen Kerr, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 29, 2018
"Teachable Moment" Interventions in Lung Cancer: Why Action MattersCarolyn Dresler, Graham W Warren, Douglas Arenberg, et al.
Translational Lung Cancer Research|March 18, 2024
"We need to work towards it, whatever it takes."-participation factors in the acceptability and feasibility of lung cancer screening in Australia: the perspectives of key stakeholdersRachael Helen Dodd, Ashleigh Rebecca Sharman, Mei Ling Yap, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2019
Pharmacokinetics and Tolerability of Intravenous Sulbactam-Durlobactam with Imipenem-Cilastatin in Hospitalized Adults with Complicated Urinary Tract Infections, Including Acute PyelonephritisOlexiy Sagan, Ruslan Yakubsevitch, Krassimir Yanev, et al.
Asia-Pacific Journal of Clinical Oncology|May 28, 2016
Closing evidence-practice gaps in lung cancer: Results from multi-methods priority setting in the clinical contextDeborah McGregor, Nicole Rankin, Phyllis Butow, et al.
Respirology (Carlton, Vic.)|April 12, 2018
Consensus minimum data set for lung cancer multidisciplinary teams: Results of a Delphi processEmily Stone, Nicole Rankin, Jane Phillips, et al.
JAMA Oncology|April 27, 2023
Implementing Smoking Cessation Interventions for Tobacco Users Within Oncology Settings: A Systematic ReviewAlison L Young, Elena Stefanovska, Christine Paul, et al.
Preventive Medicine|February 28, 2023
Education messages and strategies to inform the public, potential screening candidates and healthcare providers about lung cancer screening: A systematic reviewRachael H Dodd, Ashleigh R Sharman, Deborah McGregor, et al.
Translational Lung Cancer Research|November 7, 2024
Systems mapping: a novel approach to national lung cancer screening implementation in AustraliaSandra Marjanovic, Andrew Page, Emily Stone, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Clinical Spine Surgery|November 23, 2016
The Influence of Histologic Subtype in Predicting Survival of Lung Cancer Patients With Spinal MetastasesNaresh Kumar, Kimberly-Anne Tan, Jiong Hao Tan, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort studyEmily Stone, Nicole Rankin, Stephen Kerr, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 29, 2018
"Teachable Moment" Interventions in Lung Cancer: Why Action MattersCarolyn Dresler, Graham W Warren, Douglas Arenberg, et al.
Translational Lung Cancer Research|March 18, 2024
"We need to work towards it, whatever it takes."-participation factors in the acceptability and feasibility of lung cancer screening in Australia: the perspectives of key stakeholdersRachael Helen Dodd, Ashleigh Rebecca Sharman, Mei Ling Yap, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2019
Pharmacokinetics and Tolerability of Intravenous Sulbactam-Durlobactam with Imipenem-Cilastatin in Hospitalized Adults with Complicated Urinary Tract Infections, Including Acute PyelonephritisOlexiy Sagan, Ruslan Yakubsevitch, Krassimir Yanev, et al.
Asia-Pacific Journal of Clinical Oncology|May 28, 2016
Closing evidence-practice gaps in lung cancer: Results from multi-methods priority setting in the clinical contextDeborah McGregor, Nicole Rankin, Phyllis Butow, et al.
Respirology (Carlton, Vic.)|April 12, 2018
Consensus minimum data set for lung cancer multidisciplinary teams: Results of a Delphi processEmily Stone, Nicole Rankin, Jane Phillips, et al.
JAMA Oncology|April 27, 2023
Implementing Smoking Cessation Interventions for Tobacco Users Within Oncology Settings: A Systematic ReviewAlison L Young, Elena Stefanovska, Christine Paul, et al.
Preventive Medicine|February 28, 2023
Education messages and strategies to inform the public, potential screening candidates and healthcare providers about lung cancer screening: A systematic reviewRachael H Dodd, Ashleigh R Sharman, Deborah McGregor, et al.
Translational Lung Cancer Research|November 7, 2024
Systems mapping: a novel approach to national lung cancer screening implementation in AustraliaSandra Marjanovic, Andrew Page, Emily Stone, et al.
Pageof 13